Administration & Agency Updates

Recent Administration & Agency Updates

White House Releases Dear Tribal Leader on American Rescue Plan Funding to Indian Country

On April 16, the White House released a Dear Tribal Leader outlining the over $4 Billion in funding provided to Indian Country in the American Rescue Plan to combat COVID-19. The letter highlights: $600 Million to increase COVID-19 vaccinations in Indian Country $1 billion to detect, diagnose, trace, monitor, and mitigate COVID-19 infections $2 billion for tribal health systems due to lost reimbursements for…

Announcement of Pause in Use of Johnson & Johnson/Janssen Vaccine

On April 13, the Centers for Disease Control and Prevention (CDC) and Food and Drug Administration recommended that all hospitals, clinics, and other providers sites, including Indian Health Service (IHS) and Tribal health facilities and clinics, pause the use of the Johnson & Johnson’s Janssen COVID-19 vaccine due to reports of adverse events. In the United States, there have been six reported cases of a rare…

CDC Issues First Set of Guidelines on How Fully Vaccinated People Can Visit Safely with Others

On Monday, March 8, 2021, the Centers for Disease Control and Prevention (CDC) issued its first set of recommendations on activities that people who are fully vaccinated against COVID-19 can safely resume. The new guidance—which is based on the latest science — includes recommendations for how and when a fully vaccinated individual can visit with other people who are fully vaccinated and with other…

FDA Issues Emergency Use Authorization for Janssen COVID-19 Vaccine

On February 27, Food and Drug Administration (FDA) approved an Emergency Use Authorization (EUA) for the Janssen (Johnson & Johnson) COVID-19 Vaccine and on February 28, Janssen’s single-dose COVID-19 vaccine was unanimously recommended by the Center for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices. Important information about the Janssen (J&J) vaccine: 66.1% effective in preventing moderate to severe COVID-19 infections 85.4% effective against severe or…

Contact Us

To reach the NIHB COVID-19 Response Team, please contact [email protected].

For media inquiries, please contact April Hale at [email protected].

© Copyright 2020, National Indian Health Board. All Rights Reserved. Website by DrawBridge Creative.

Privacy Policy

This website is supported by the Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award totaling $2,000,000 with 70 percent funded by CDC/HHS, and 30 percent funded by non-government source(s). The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by CDC/HHS, or the U.S. Government.